000 | 01514cam a2200277 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
005 | 20250223032021.0 | ||
008 | 180711s2017 ua dh f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aGift | ||
097 | _aM.Sc | ||
099 | _aCai01.34.M.Sc.2017.Es.E | ||
100 | 0 | _aEsraa Osama Abdelaziz Mostafa | |
245 | 1 | 0 |
_aEffect of thymoquinone on Ü7 nicotinic acetylcholine receptor in LPS- induced neuroinflammatory Alzheimer's disease rat model / _cEsrss Osama Abdelaziz Mostafa ; Supervised Ola Heikal , Lobna Abdelaal Kassem |
260 |
_aCairo : _bEsrss Osama Abdelaziz Mostafa , _c2017 |
||
300 |
_a139 Leaves : _bcharts , facsimiles ; _c30cm |
||
502 | _aThesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmacology and toxicology | ||
520 | _aAlzheimer's disease (AD) is a neurodegenerative disorder resulting from the loss of cholinergic nerurons in the brain. It has been reported that Ü7 nicotinic acetylcholine receptors(Ü7 nAChRs) play an important role in cognitive processes representing a durg target for treating congnitive deficits. Ü7 nAChRs agonists cause memory enhancement through phosphorylation of cAMP response element binding protein (CREB) | ||
700 | 0 |
_aLobna Abdelaal Kassem , _eSupervisor |
|
700 | 0 |
_aOla Heikal , _eSupervisor |
|
856 | _uhttp://172.23.153.220/th.pdf | ||
905 |
_aNazla _eRevisor |
||
905 |
_aShimaa _eCataloger |
||
942 |
_2ddc _cTH |
||
999 |
_c66737 _d66737 |